Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.58 -0.40 (-0.90%)
As of: Sep 30, 2026 · 2:10 PM EDT

Supernus Pharmaceuticals, Inc. (SUPN) Short term Debt (2011 - 2023)

Updated

Supernus Pharmaceuticals' Short term Debt came in at $78.36 million for Q1 2023.

Analysis

Supernus Pharmaceuticals, Inc. (SUPN) Short term Debt (2011 - 2023) Analysis & Trends

At the end of FY2012, Supernus Pharmaceuticals' Short term Debt was $11.81 million, up 74.3% from FY2011.

  • Going back by year, Short term Debt was $6.78 million in FY2011.
  • The Q1 2023 figure represents the lowest quarterly Short term Debt since Q1 2013.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 78.36 Mn
Sep 30, 2022 401.44 Mn
Jun 30, 2022 400.91 Mn
Mar 31, 2013 12.14 Mn
Dec 31, 2012 11.81 Mn
Sep 30, 2012 11.49 Mn
Jun 30, 2012 10.75 Mn
Mar 31, 2012 9.17 Mn
Dec 31, 2011 6.78 Mn
API Access

Supernus Pharmaceuticals, Inc. Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=SUPN&period=max&api_key=YOUR_API_KEY